CCN2 and early-onset autosomal dominant Alzheimer disease: Increased levels of CTGF have been detected in both astrocytes and neurons in the brains of patients with MS, Alzheimer’s disease, and amyotrophic lateral sclerosis, as well as in glioblastoma (59).